Aquestive Therapeutics, Inc. (AQST) vs Ironwood Pharmaceuticals, Inc. (IRWD)
- Aquestive Therapeutics, Inc. AQST 3.78 −6.90%
- Ironwood Pharmaceuticals, Inc. IRWD 3.50 −7.16%
Aquestive Therapeutics, Inc. and Ironwood Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Ironwood Pharmaceuticals, Inc. is the larger, with a market value of $623.0M against $509.6M — 1.2× the size. Aquestive Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Ironwood Pharmaceuticals, Inc. trades at 4.4×. Ironwood Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 26.2% against 22.6%. Ironwood Pharmaceuticals, Inc. has the higher net margin (33.4% vs −144.6%) and the higher return on invested capital (101.6% vs 0.00%). Across the 18 metrics below, Ironwood Pharmaceuticals, Inc. leads on 13 and Aquestive Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | AQST | IRWD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 67.04% | 100.00% | 53.94% |
| Operating margin | (97.52%) | 60.15% | 0.00% |
| Net margin | (144.63%) | 33.36% | 0.00% |
| Free cash flow margin | (84.95%) | 47.66% | 0.00% |
| Return on equity | 121.12% | (55.26%) | (0.40%) |
| Return on assets | (69.29%) | 41.35% | (3.32%) |
| Return on invested capital | 0.00% | 101.61% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack